Symbols

IBRX

ImmunityBio·NASDAQ

--(--)

9.90 / 10

Outperform

Sentiment is Outperform (9.9) and fund‑flow score 7.84, with small/medium inflows positive but large/extra‑large negative. Analyst consensus is 75% Strong Buy, 25% Buy, backed by high historical win rates. Overall sentiment and money flow support a bullish outlook.

Fund Flow Rating

Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

75%

Buy

25%

Hold

Sell

Strong Sell

Date2026-03-04

InstitutionPiper Sandler

Times predicted1

Historical Win Rate0.0%

Is money flowing into or out of IBRX?

IBRX holds a Bullish analyst rating, with 75% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 9.90/10 (Outperform).